Search results
Results from the WOW.Com Content Network
In general, the severity of cancer increases with a shorter duration of time between initial treatment and its return. [3] Cancers with the highest recurrence rates include Glioblastoma with a recurrence rate of almost 100%, [5] Epithelial ovarian cancer with a recurrence rate of 85%, [6] and Bladder cancer with a recurrence rate of 30-54% [7]
In the United States there has been an increase in the 5-year relative survival rate between people diagnosed with cancer in 1975-1977 (48.9%) and people diagnosed with cancer in 2007-2013 (69.2%); these figures coincide with a 20% decrease in cancer mortality from 1950 to 2014. [8]
In the United States during 2013–2017, the age-adjusted mortality rate for all types of cancer was 189.5/100,000 for males, and 135.7/100,000 for females. [1] Below is an incomplete list of age-adjusted mortality rates for different types of cancer in the United States from the Surveillance, Epidemiology, and End Results program.
Cancer rates in young and middle-aged women are rising, surpassing those in men of the same age—most alarmingly in women under 50, whose rates are now 82% higher than those of their male ...
Increasingly, though, young adults are now facing a higher risk of cancer. Colorectal cancer rates are up for people under 65; cervical cancer is on the rise in women between 30 and 44 years old ...
This is a list of countries by cancer frequency, as measured by the number of new cancer cases per 100,000 population among countries, based on the 2018 GLOBOCAN statistics and including all cancer types (some earlier statistics excluded non-melanoma skin cancer).
Cancer survival is typically based on 5-year survival rates which is the survival rate compared to women without breast cancer and is based on the stage when the cancer is first diagnosed. These statistics do not apply if the cancer returns after treatment. [6]
For example, prostate cancer has a much higher one-year overall survival rate than pancreatic cancer, and thus has a better prognosis. Sometimes the overall survival is reported as a death rate (%) without specifying the period the % applies to (possibly one year) or the period it is averaged over (possibly five years), e.g. Obinutuzumab: A ...